Phase II study with conventional radiotherapy (RT) + cetuximab in patients with advanced larynx cancer who responded to induction chemotherapy (IC): An organ preservation TTCC study

Authors :: Joaquina Martinez Galan
M. Pastor
Javier Martínez Trufero
Silvia Vazquez
Jordi Rubió
Elvira del Barco
Angeles Rodriguez Jaraiz
Esther Casado
Ricard Mesia
Julio Jose Lambea Sorrosal
José Ángel García Sáenz
Miren Taberna
Juan Jesús Cruz
Juan J. Grau
Beatriz Cirauqui
Alicia Lozano
J. R. Mel
Belen Gonzalez
Manel Manos Pujol
Source :: Journal of Clinical Oncology. 33:6037-6037
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: 6037 Background: IC with docetaxel/cisplatin/fluorouracil (TPF) is superior to PF in organ preservation. Bioradiotherapy (BRT) is superior to RT alone in the loco-regional control of locally-advanc...

Subjects :: Cisplatin
Oncology
Larynx
Cancer Research
medicine.medical_specialty
Cetuximab
business.industry
Phases of clinical research
Induction chemotherapy
Cancer
medicine.disease
medicine.anatomical_structure
Docetaxel
Fluorouracil
Internal medicine
medicine
business
medicine.drug

Tools